Epi-Allele elicits compensatory expression of the non-targeted allele and prevents haploinsufficiency in dominant genetic diseases.

Epi-Allele induces compensatory expression of non-targeted alleles, maintaining total gene expression and preventing haploinsufficiency in dominant genetic diseases.

• Why it matters: Haploinsufficiency limits current allele-specific therapies for dominant diseases, and understanding allelic expression regulation could improve treatment safety and efficacy.
• What they did: Researchers developed Epi-Allele, an allele-specific epigenetic editing method, and found genome-wide evidence that compensated allelic expression is common, validated in mouse and human cell models.
• The result: Epi-Allele's ability to preserve total gene expression suggests it can avoid haploinsufficiency, offering a promising, allele-specific therapeutic strategy for dominant genetic disorders.